approves Medtronic's

FDA Approves Medtronic’s Onyx Frontier Drug-Eluting Stent

The US Food and Drug Administration (FDA) has approved the Onyx Frontier drug-eluting stent (DES) to treat patients with coronary artery disease, the device manufacturer, Medtronic, announced today. The Onyx Frontier shares the same stent platform and clinical indications as the previous generation Resolute Onyx zotarolimus-eluting stent, including the most recent approval for patients at…

approves Israel

Israel approves more than 4,000 settlement homes: Rights group

Israel advanced plans for the construction of more than 4,000 homes in illegal Israeli settlements in the occupied West Bank, a rights group has said, a day after the Israeli army demolished homes in an area where hundreds of Palestinians face the threat of expulsion. Peace Now, an anti-settlement group, provided the figure after a…

approves Wilson’s

FDA approves new drug for Wilson’s disease

The US Food and Drug Administration (FDA) has approved oral trientine tetrahydrochloride (Cuvrior, Orphalan) for the treatment of adults with stable Wilson’s disease who are decoppered and tolerant to penicillamine, the company has announced. Wilson’s disease is a rare genetic storage disease caused by a defect in a copper transporter gene, leading to copper accumulation…

approves Beijing

Beijing approves driverless taxi permits for Baidu and

Beijing is paving the way for driverless robotaxis. China’s capital city granted permits to auto startup and Chinese internet giant to offer self-driving car services to the general public, both companies announced today. Both operations will start out small — Baidu’s fleet will consist of 10 cars and will run four cars, CNBC. Eventually…

approves first

FDA approves first COVID treatment for children

By Cara Murez and Robin Foster HealthDay Reporters HealthDay Reporter TUESDAY, April 26, 2022 (HealthDay News) – The U.S. Food and Drug Administration on Tuesday approved the antiviral remdesivir as the first COVID-19 treatment for young children. The drug had so far only been available to this age group under a special FDA emergency use…

approves Leadless

FDA Approves Leadless, Single-Chamber Pacemaker System

The Food and Drug Administration has granted approval to Abbott’s Aveir leadless, single-chamber pacemaker system for patients with bradycardia. In a press release, Abbott said the device has a unique mapping capability that allows interventionists implanting the device to measure electrical signals within the heart to determine the correct placement before final implantation. Aveir is implanted…

approves Sweden

Sweden approves controversial iron mine on Indigenous Sami land

The Swedish government has greenlit a controversial iron mine that Indigenous people say threatens their livelihoods. Beowulf Mining, a British company, will now begin an environmental review of its Kallak Mine project and apply to start processing ore. The mine has been strongly opposed by the Indigenous Sami in Sweden, as well as the United…

approves Radioligand

FDA approves new radioligand therapy and diagnostic for mCRPC

The US Food and Drug Administration (FDA) has approved a new radioligand treatment for certain men with metastatic castration-resistant prostate cancer (mCRPC), as well as a new radioligand diagnostic agent for use in imaging to identify men who are suitable for this treatment. The new therapy is lutetium Lu 177 vipivotide tetraxetan (Pluvicto, from Advanced…

approves Senate

Senate approves bill making daylight saving time permanent

National Sunlight shines on the U.S. Capitol dome on Capitol Hill in Washington, Monday, Feb. 21, 2022. (AP Photo/Patrick Semansky) The Associated Press By FARNOUSH AMIRI, Associated Press March 15, 2022 | 4:42 PM WASHINGTON (AP) — The Senate unanimously approved a measure Tuesday that would make daylight saving time permanent across the United States…

approves Secnidazole

FDA approves Secnidazole in BV, Trichomoniasis Treatments for Adolescents

The Food and Drug Administration has approved secnidazole for the treatment of bacterial vaginosis (BV) and trichomoniasis in patients aged 12 years and older. The antimicrobial agent, marketed as Solosec, was first approved in 2017 as a treatment for BV in adult women. In 2021, it was approved for the treatment of trichomoniasis in adult men and…